Analyst Price Targets — KEX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 29, 2026 1:47 pm | Greg Lewis | BTIG | $170.00 | $133.57 | StreetInsider | BTIG Reiterates Buy Rating on Kirby Corporation (KEX) |
| May 1, 2026 12:06 pm | Jonathan Chappell | Evercore ISI | $158.00 | $145.96 | TheFly | Kirby price target raised to $158 from $138 at Evercore ISI |
| April 15, 2026 11:13 am | — | BTIG | $160.00 | $142.63 | TheFly | Kirby price target raised to $160 from $135 at BTIG |
| March 9, 2026 7:39 pm | Jonathan Chappell | Evercore ISI | $138.00 | $125.81 | StreetInsider | Evercore ISI Reiterates Outperform Rating on Kirby Corporation (KEX) amid "Overreaction to Jones Act Headline" |
| January 30, 2026 1:54 pm | — | Wolfe Research | $136.00 | $117.87 | TheFly | Kirby price target raised to $136 from $134 at Wolfe Research |
| January 15, 2026 12:26 pm | Gregory Lewis | BTIG | $140.00 | $124.32 | TheFly | Kirby price target raised to $140 from $125 at BTIG |
| January 8, 2026 8:21 pm | — | Wolfe Research | $134.00 | $125.99 | TheFly | Kirby price target raised to $134 from $119 at Wolfe Research |
| October 9, 2025 12:20 pm | — | Evercore ISI | $109.00 | $82.23 | TheFly | Kirby price target lowered to $109 from $122 at Evercore ISI |
| April 19, 2024 7:18 am | Benjamin Nolan | Stifel Nicolaus | $118.00 | $94.97 | TheFly | Kirby price target raised to $118 from $100 at Stifel |
| April 3, 2024 5:17 am | Greg Lewis | BTIG | $115.00 | $94.56 | StreetInsider | Kirby Corporation (KEX) PT Raised to $115 at BTIG |
Latest News for KEX
While the top- and bottom-line numbers for Kirby (KEX) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
New York, New York--(Newsfile Corp. - October 28, 2026) - The law firm of Kirby McInerney LLP continues its investigation on behalf of Arrivent BioPharma ("Arrivent" or the "Company") (NASDAQ: AVBP) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices. [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What…
Kirby (KEX) came out with quarterly earnings of $2.09 per share, beating the Zacks Consensus Estimate of $1.96 per share. This compares to earnings of $1.65 per share a year ago.
HOUSTON, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Kirby Corporation (“Kirby” or “the Company”) (NYSE: KEX) today announced net earnings attributable to Kirby for the third quarter ended September 30, 2026, of $110.8 million, or $2.09 per share, compared with earnings of $92.5 million, or $1.65 per share, for the 2025 third quarter. Total revenues for the 2026 third quarter were $977.2 million compared with $871.2 million…
Crossmark Global Holdings Inc. lowered its position in Kirby Corporation (NYSE: KEX) by 77.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,449 shares of the shipping company's stock after selling 15,509 shares during the period. Crossmark
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for KEX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.